The Pathogenesis of Human Immunodeficiency Virus

1784 Words4 Pages

The human immunodeficiency virus, known more commonly as HIV or by the syndrome it ultimately leads to the acquired immunodeficiency syndrome or AIDs, is caused by a RNA retrovirus.1 Morphologically, the virus appears spherical in shape and is enveloped made from two layers – both being primarily built using lipids taken from host cell membranes.2 Specifically, human cell membranes are taken up by the virus as it buds from the host cell2 after the host cell approaches death from the inability to meet its own physiological needs. Likewise, because the hosts’ membrane coats or more accurately ‘envelopes’ the virus, the hosts’ proteins are embedded within the membrane and on the membrane’s surface as well.2 However, the last essential component to the virus’ morphology is the proteins that aren’t from the host that are also embedded into the envelope. In fact, these proteins called Env proteins are a complex HIV protein encoded for by the virus which is produced by the host, but not inherent to the host cell itself. What this Env proteins on the viral envelope do is that they form a cap made of three glycoprotein 120 (gp120) molecules as well as an attached stem for those 3 gp120 molecules made of glycoprotein 41 (gp41) that, when combined, act as a virulence factor by helping to both maintain the host cell membrane-envelope stability and to act as a means of attaching to more host cells as well.2 Moving on away from the envelope, the capsid of HIV is bullet-shaped, and made up mainly with about 2000 copies of viral protein p24 which surround 2 single-stranded RNA molecules characteristic of HIV.2
Continuing on from the inside of HIV, the RNA strands it carries may encode for virulence factor genes. Notable genes include nef which i...

... middle of paper ...

...n even faster change in antigenic proteins.1 Despite many companies and organizations developing promising vaccines during clinical trials, to this date no effective vaccine for HIV, or “AIDS vaccine” has been developed as of yet. The most recent clinical trial for a HIV vaccine was for HVTN 505 which was a combination a DNA vaccine that encoded for artificially modelled surface and internal structures similar to that of HIV (to be produced by host cells to prime immune system), alongside a recombinant DNA vaccine using adenovirus 5 as a live vector vaccine (meaning that this vector displayed common HIV antigens).6 HVTN 505 was a failure, but people around the world have not given up hope on finding a vaccine or cure for HIV and AIDs, and they likely won’t for many years to come as long as hundreds of thousands of people continue to die from this disease every year.

Open Document